Related Experiment Video
Updated: Mar 26, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.9K
Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive
Carmen V Leitner1, Ines A Ederer1, Michela de Martino1
1Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
The Journal of Urology
|February 3, 2016
Summary
Recurrence and progression rates in nonmuscle invasive bladder cancer decrease over time. Established risk factors lose prognostic impact, but Bacillus Calmette-Guérin shows long-term protection against progression.
Area of Science:
- Urology
- Oncology
- Cancer Research
Background:
- Nonmuscle invasive bladder cancer (NMIBC) recurrence and progression are significant concerns.
- Dynamic prediction of outcomes using conditional estimates is valuable but lacks data for NMIBC.
Purpose of the Study:
- To assess changes in conditional recurrence and progression rates for NMIBC post-transurethral resection.
- To explore the evolving prognostic impact of established factors and risk groups over time.
Main Methods:
- Retrospective analysis of 1,292 consecutive patients with newly diagnosed Ta/T1 bladder cancer.
- Transurethral resection of the bladder as the primary treatment.
- Evaluation of time to first recurrence and time to progression as study endpoints.
Main Results:
- The 2-year recurrence rate improved from 36% at baseline to 11% at 48 months.
- Conditional progression rates also improved with follow-up, though less distinctly.
- Prognostic impact of risk factors diminished over time, while Bacillus Calmette-Guérin demonstrated sustained protective effects on progression.
Conclusions:
- Recurrence and progression rates in NMIBC improve with longer disease-free intervals.
- The prognostic significance of traditional risk factors wanes over time.
- Conditional outcome estimates can enhance patient counseling and personalize surveillance strategies for bladder cancer.
Related Concept Videos
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Cancer Survival Analysis
822
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
822

